Of course the ChatGPT dog cancer vaccine spawned a startup

Paul Conyngham, the Australian entrepreneur who claimed to have used ChatGPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog Rosie, has launched a startup called Gamgee. The company aims to offer personalized mRNA cancer vaccines for dogs, but its ambitions extend to other species, including humans. Gamgee's website prominently features Rosie and uses an AI-generated anime launch video. Conyngham says on X that he used ChatGPT and computational genomics to design the vaccine, and several of Rosie's tumors shrank. However, a prior Verge investigation found that the science is messier than claimed: the exact role of AI was unclear, and Rosie also received another therapy, making it impossible to attribute her improvement solely to the vaccine. Despite this, Gamgee is backed by Y Combinator and is recruiting for clinical trials in Australia, with a waitlist elsewhere. The website touts a 75% tumor reduction in its first documented case but cautions that it is based on a single case. Gamgee collaborates with the University of Queensland and institutes at the University of New South Wales.